Fingolimod Hydrochloride Synthesis Suppressing Styrene Impurity

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for synthesizing fingolimod hydrochloride result in significant formation of styrene impurity during the coupling of 2-(4-octylphenyl)ethyl iodide with diethyl acetamidomalonate, requiring multiple purification steps and reducing yield, with no prior art methods effectively limiting or eliminating this impurity in a single step.

Innovation Solution

The process involves reacting 2-(4-octylphenyl)ethyl iodide with diethyl acetamidomalonate in the presence of a base and an iodinating agent, such as quaternary ammonium salts or alkali metal iodides, to suppress styrene impurity formation, followed by reduction and conversion to fingolimod hydrochloride without additional purification steps.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If coupling reaction is performed using conventional base alone, then reaction proceeds, but styrene impurity forms to extent of 10-15%

Engineering Contradiction:
Improvepurity of condensation intermediateVSAvoidstyrene impurity formation
Core Design Contradiction:
Manufacturing precisionVSObject-generated harmful factors

Solution Approach 1:

The patent introduces an iodinating agent as an intermediary substance that mediates the coupling reaction between 2-(4-octylphenyl)ethyl iodide and diethyl acetamidomalonate. This intermediary agent facilitates the desired condensation while suppressing the formation of styrene impurity, achieving purification through the reaction mechanism itself rather than subsequent separation steps.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes the chemical parameters of the reaction system by introducing iodinating agents (such as iodine, sodium iodide, or quaternary ammonium iodides) in combination with base. This parameter change transforms the reaction pathway to favor the desired condensation product while minimizing styrene formation, reducing impurity levels from 10-15% to below regulatory limits.

Inventive Principle:
Principle #35Parameter changes

2Manufacturing precision

If multiple purification steps are applied to remove styrene impurity, then purity increases, but manufacturing complexity and cost increase

Engineering Contradiction:
Improvepurity of final productVSAvoidnumber of purification steps
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent converts the harmful effect of base-catalyzed styrene formation into a beneficial outcome by introducing iodinating agents that redirect the reaction pathway. The same basic conditions that previously caused impurity formation now, with the addition of iodinating agents, lead to high-purity product without requiring complex purification steps.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Solution Approach 2:

The patent takes out the need for separate purification steps by incorporating the purification function directly into the condensation reaction itself. Through the use of iodinating agents, the reaction selectively produces the desired intermediate with minimal impurity formation, eliminating the need for subsequent extraction or chromatography steps.

Inventive Principle:
Principle #2Taking out (Extraction)

3Object-generated harmful factors

If alternative routes are used to eliminate styrene impurity, then impurity formation is reduced, but additional steps are required increasing manufacturing cost

Engineering Contradiction:
Improvestyrene impurity levelVSAvoidmanufacturing efficiency
Core Design Contradiction:
Object-generated harmful factorsVSProductivity

Solution Approach 1:

The patent performs preliminary action by adding iodinating agents at the very beginning of the condensation reaction, before styrene impurity can form. This preventive measure ensures that the reaction pathway is directed toward the desired product from the outset, eliminating the need for subsequent remedial purification steps or alternative reaction routes.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach significantly minimizes styrene impurity below regulatory limits, eliminating the need for column chromatography or repeated crystallization, thereby improving yield and reducing manufacturing costs while meeting regulatory specifications.

Implementation Method 1

coupling of 2-(4-octylphenyl) ethyl iodide with diethyl acetamidomalonate in presence of sodium methoxide

Methodology Applied
Scientific EffectNucleophilic substitution reaction: Chemical Bonding

Implementation Method 2

formation of impurity (II) during coupling of 2-(4-octylphenyl) ethyl iodide with diethyl acetamidomalonate wherein the associated styrene impurity (II) was usually formed

Methodology Applied
Scientific EffectElimination reaction: Chemical Bonding

Implementation Method 3

subjecting the product containing the styrene impurity to Michael reaction followed by further reduction to yield diethyl 2-acetamido-2-(4-octylphenyl)ethyl malonate

Methodology Applied
Scientific EffectReduction reaction: Reduction

Data Source

PatentEP3074374B1Fingolimod hydrochloride process
Publication Date: 2019.03.13 EMCURE PHARMACEUTICALS LTD
  • EP3074374B1 patent drawing
  • EP3074374B1 patent drawing
  • EP3074374B1 patent drawing

AI summary

A process for preparation of diethyl 2-acetamido-2-(4-octyl phenyl)ethyl malonate (III), a key intermediate of fingolimod hydrochloride comprising reaction of 2-(4- octylphenyl)ethyl iodide (IV) with diethyl acetamido malonate in presence of a base and an iodinating agent and in an organic solvent. The compound of formula (III) thus obtained provided fingolimod hydrochloride (la) having associated impurities below the regulatory limits.